Recent News

• 12.05.2025 - Iterum Therapeutics Provides Business Update
• 11.24.2025 - Iterum Therapeutics Provides Business Update
• 11.14.2025 - Iterum Therapeutics Reports Third Quarter 2025 Financial Results
• 11.07.2025 - Iterum Therapeutics to Report Third Quarter 2025 Financial Results on Friday, November 14, 2025
• 10.14.2025 - Iterum Therapeutics to Present Data at IDWeek 2025
• 10.14.2025 - Iterum Therapeutics to Present Data at IDWeek 2025
• 09.19.2025 - Iterum Therapeutics Provides Business Update
• 09.19.2025 - Iterum Therapeutics Provides Business Update
• 08.20.2025 - Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S.
• 08.20.2025 - Iterum Therapeutics launches ORLYNVAH™, the first and only oral penem antibiotic in the U.S.

Recent Filings

• 11.20.2025 - 4 Statement of changes in beneficial ownership of securities
• 11.14.2025 - 8-K Current report
• 11.14.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 11.14.2025 - EX-99.1 EX-99.1
• 10.16.2025 - 8-K Current report
• 10.16.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 09.10.2025 - 8-K Current report
• 08.28.2025 - 8-K Current report
• 08.20.2025 - 8-K Current report
• 08.20.2025 - EX-99.1 EX-99.1